PTC Therapeutics
PTCT
PTCT
115 hedge funds and large institutions have $310M invested in PTC Therapeutics in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-8
Holders Change %
-6.5%
% of All Funds
2.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
38
Reduced
34
Closed
27
Calls
$15.1M
Puts
$16.5M
Net Calls
-$1.42M
Net Calls Change
-$11.4M
Top Buyers
| 1 |
BlackRock
New York
|
+$31.6M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$14.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$14.5M |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$12.3M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$24.7M |
| 2 |
Millennium Management
New York
|
-$7.75M |
| 3 |
TAM
Tocqueville Asset Management
New York
|
-$7.19M |
| 4 |
JPMorgan Chase & Co
New York
|
-$6.77M |
| 5 |
SA
Sicart Associates
New York
|
-$4.7M |
